Q4 2025 earnings call recap: clonoSEQ MRD growth, 2026 revenue guidance, margins, cash burn and risks—read now.

Emerson Electric Co (EMR) reports robust order growth and increased earnings, despite facing headwinds in Europe and China.

Adaptive Biotechnologies Corporation (NASDAQ:ADPT) Q4 2025 Earnings Call Transcript February 5, 2026 Adaptive Biotechnologies ...

Engineering and automation solutions company Emerson (NYSE:EMR) met Wall Streets revenue expectations in Q4 CY2025, with ...

Most readers would already be aware that Emerson Electric's (NYSE:EMR) stock increased significantly by 8.8% over ...

Emerson’s fourth quarter results received a positive market response, as the company met Wall Street’s revenue expectations ...

Understand the advantages of PC-driven hearing tests over legacy equipment in terms of cost, scalability, and usability.

Investors will scrutinize the path to profitability. The company expects to achieve positive adjusted EBITDA and positive ...

Health information systems are digital platforms that collect, store, manage, and transmit medical data across healthcare facilities.

Q1 2026 earnings call: order growth, raised EPS guidance, margin outlook, AI automation and risks in Europe/China.

Apollo Hospitals signs MoU with Roche Diagnostics India to advance digital innovation in clinical care at THIT 2026: Our Bureau, Mumbai Saturday, January 31, 2026, 14:15 Hrs [IST] ...

Applications are invited for recruitment of teaching and non-teaching positions or career in NIPER Guwahati Assam in 2026. National Institute ...